Urinary tract infections in women with or at risk for human immunodeficiency virus infection

American Journal of Obstetrics and Gynecology

Volumn 187, Issue 3, 2002, Pages 581-588

  Park, John C ^a   Buono, Donna ^a   Smith, Dawn K ^b   Peipert, Jeffrey F ^c   Sobel, Jack ^d   Rompalo, Anne ^e   Klein, Robert S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c BROWN UNIVERSITY   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacterial infection; Epidemiology; Urinary tract; Women

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; PREGNANCY TEST; PRIORITY JOURNAL; RISK ASSESSMENT; SEROLOGY; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE; VIRUS LOAD;

EID: 0036737599     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2002.125894     Document Type: Article

References (25)

1. Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545-50.
2. Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995;333:845-51.
3. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Morbid Mortal Wkly Rep 2000;49(RR-6):1-51.
4. Alpert PL, Munsiff SS, Gourevitch MN, Greenberg BL, Klein RS. A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival. Clin Infect Dis 1997;24:661-8.
5. Warren JW. Clinical presentations and epidemiology of urinary tract infection. In: Mobley HLT, Warren JW, editors. Urinary tract infections: molecular pathogenesis and clinical management. Baltimore: ASM Press; 1996. p. 3-27.
6. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 1999;11:1-44.
7. Hoepelman AI, van Buren M, van den Brock J, Borleffs JC. Bacteriuria in men infected with HIV-1 is related to their immune status (CD4+ cell count). AIDS 1992;6:179-84.
8. Evans JK, McOwan A, Hillman RJ, Forster GE. Incidence of symptomatic urinary tract infections in HIV seropositive patients and the use of co-trimoxazole as prophylaxis against Pneumocystis carinii pneumonia. Genitourinary Medicine 1995;71:120-2.
9. De Pinho AM F, Lopes GS, Ramos-Filho CF, et al. Urinary tract infection in men with AIDS. Genitourinary Medicine 1994:70:30-4.
10. Schonwald S, Begovac J, Skerk V. Urinary tract infections in HIV disease. Int J Antimicrob Agents 1999;11:309-11.
11. Smith DK, Warren DL, Vlahov D, et al. Design and baseline participant characteristics of the human immunodeficiency virus epidemiology research (HER) study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol 1997;146:459-69.
12. Kunin CM. Detection, prevention and management of urinary tract infections. Philadelphia: Lea & Febiger; 1987.
13. Joint United Nations Programme on HIV/AIDS. Report on the global HIV/AIDS epidemic. Geneva: UNAIDS; 2000.
14. Kaplan MS, Wechsler M, Benson MC. Urologic manifestations of AIDS. Urology 1987;30:441-3.
15. Ojoo J, Paul J, Batchelor B, et al. Bacteriuria in a cohort of predominantly HIV-1 seropositive female commercial sex workers in Nairobi, Kenya. J Infect 1996;33:33-7.
16. Agace W, Connell H, Svanborg C. Host resistance to urinary tract infection. In: Mobley HLT, Warren JW, editors. Urinary tract infections molecular pathogenesis and clinical management. Washington, DC: ASM Press; 1996. p. 221-43.
17. Barnes RC, Daifuku R, Roddy RE, Stamm WE. Urinary tract infections in sexually active homosexual men. Lancet 1986;1:171-3.
18. Hooton TM, Stamm WE. Management of acute uncomplicated urinary tract infection in adults. Med Clin North Am 1991;75:339-57.
19. Masihi KN, Lange W, Rohde-Schulz B. Exacerbation of human immunodeficiency virus infection in promonocytic cells by bacterial immunomodulators. J Acquir Immune Defic Syndr 1990;3:200-5.
20. Goletti D, Weissman D, Jackson RW, et al. Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation. J Immunol 1996;157:1271-8.
21. Hooton TM, Scholes D, Hughes JP, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996;335:468-74.
22. Ferry SL, Burman LG, Holm SE. Clinical and bacteriological effects of therapy of urinary tract infection in primary health care: relation to in vitro sensitivity testing. Scan J Infect Dis 1988;20:535-44.
23. Boscia JA, Kobasa W, Knight RA, Abrutyn E, Levison ME, Kaye D. Epidemiology of bacteriuria in an elderly ambulatory population. Am J Med 1986;80:208-13.
24. Centers for Disease Control and Prevention. 1993 revisited classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morbid Mortal Wkly Rep 1992;41(RR-17):1-19.
25. Smith SD, Wheeler MA, Weiss RM. Detection of urinary tract infections by reduction of nitroblue tetrazolium. Kidney Int 1998;54:1331-6.